Mortality, Morbidity and Risk Factors of Liver Retransplantation

Comparison of Mortality, Morbidity and Risk Factors in Living- Donor and Deceased-Donor Liver Retransplantation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04789213

Enrollment

Registered

2021-03-09

Start date

2021-03-10

Completion date

2021-05-01

Last updated

2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis, Liver Diseases, Liver Failure, Liver Transplant; Complications, Liver Transplant Failure, Liver Transplant Rejection, Organ Transplant Failure or Rejection

Brief summary

This study aims to compare the short and long term outcomes of living donor and deceased donor liver retransplantation. Bearing that in mind, the investigators will retrospectively analyze the files of patients whom underwent a liver retransplantation in Memorial Bahcelievler Hospital Organ Transplantation Center.

Interventions

OTHERLiver Transplantation

Liver Transplantation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Months to No maximum

Healthy volunteers

Inclusion criteria

* Having a liver retransplantation

Exclusion criteria

* N/A

Design outcomes

Primary

Measure	Time frame	Description
Survival ratio	1 minutes	Overall graft and patient survival ratio

Secondary

Measure	Time frame	Description
Morbidity	10 minutes	Postoperative complications such as septicemia, hepatic artery thrombosis etc.
Peri-operative informations	15 minutes	Peri-operative informations such as blood loss during surgery
Blood Test Results	20 minutes	Patients' blood test results specific to liver such as International Normalization Ratio

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026